Nature Communications · 2019 · 127 citations · 17 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyCell-penetrating PeptidesImmune Cell InfiltrationImmunotherapy For Solid TumorsLymphocyte TraffickingTumor-infiltrating LymphocytesAdoptive ImmunotherapyImmunotherapy For Gastric CancerLeukocyte Transendothelial MigrationLymphocyte MigrationT Cell Infiltration EnhancementT Cell Migration Into TumorsTyrosine Phosphorylation SignalingVe-cadherin Regulation
Poor infiltration of activated lymphocytes into tumors represents a fundamental factor limiting the therapeutic effect of adoptive cell immunotherapy. A tumor-penetrating peptide, iRGD, has been widely used to deliver drugs into tumor tissues. In this study, we demonstrate for the first time that iRGD could also facilitate the infiltration of lymphocytes in both 3D tumor spheroids and several xenograft mouse models. In addition, combining iRGD modification with PD-1 knockout lymphocytes reveals a superior anti-tumor efficiency. Mechanistic studies demonstrate that the binding of iRGD to neuropilin-1 results in tyrosine phosphorylation of the endothelial barrier regulator VE-cadherin, which plays a role in the opening of endothelial cell contacts and the promotion of transendothelial lymphocyte migration. In summary, these results demonstrate that iRGD modification could promote tumor-specific lymphocyte infiltration, and thereby overcome the bottleneck associated with adoptive immune cell therapy in solid tumors.
17
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass, Vésteinn Thórsson, David Van Den Berg et al. · Nature · 2014 · 6.5K citations · Full text
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Kazuki N. Sugahara, Tambet Teesalu, Priya Karmali et al. · Science · 2010 · 1.1K citations · Full text
Pharmacy, Oncology, Pharmacology +17
Edmund K. Moon, Carmine Carpenito, Jing Sun et al. · Clinical Cancer Research · 2011 · 521 citations · Full text
Medicine, Immunology, Oncology +17